Pritesh advises clients on strategy, protection and enforcement of their patent and design rights.
Pritesh joined AJ Park in early 2018. As a patent attorney in the firm’s Auckland engineering/IT team, he advises clients on strategy, protection and enforcement of their patent and design rights in New Zealand and overseas.
His main areas of expertise include drafting and prosecution of patents in the fields of mechanical engineering, electronics, robotics, business methods, IT, software, fintech and AI technologies. He also carries out all types of patent searches and analysis including novelty, validity and freedom to operate.
Identifying and prioritising areas that may need intellectual property (IP) protection should be a key part of any business strategy. IP is not just there for defensive purposes; for some businesses, it can be their biggest asset.
Pritesh’s clients range from individuals and SMEs to universities and large multi-national corporates. Most are based in New Zealand, Australia, Hong Kong and mainland China.
Friendly, professional and approachable, Pritesh enjoys the variety of his job and the opportunity to work with clients of all sizes. He likes to develop close relationships with his clients and really get to know what drives them. Pritesh believes business goals should be challenging, yet achievable, and prefers to take the necessary time to help his clients secure robust IP protection.
While pursuing his Master’s degree in engineering, Pritesh sought to use his engineering and technical skills in a different way. In 2010, he took a position as a patent examiner with the Intellectual Property Office of New Zealand (IPONZ), initially working in the mechanical team and then moving to electronics/ICT. He subsequently joined a well-known New Zealand IP firm and became a registered patent attorney, acting before both IPONZ and the Australian Intellectual Property office.
Also an Australian trade mark attorney, Pritesh has experience representing clients in both patent and trade mark hearings, and in helping prepare oppositions and revocation proceedings.
Beyond the office
Outside of work Pritesh is an avid traveller who has trekked in Nepal, wandered the streets of Manhattan, hiked the Great Wall of China, snorkelled in Fiji, taken a dip in the Ganges River, tried every possible street food in Bangkok and walked on Minnesota’s frozen lakes. He’s also a ‘kitchen scientist’ who loves experimenting with food and producing culinary creations.
- BE (Hons) (Mechatronics), Massey University (2009)
- ME (Mechatronics), Massey University (2011)
- Registered Patent Attorney (New Zealand and Australia)
- Registered Trade Mark Attorney (Australia)
Pritesh Lohani 's insights
Article \ 28 Sep 2021
AI inventorship: ‘The Rise of the Machines’ in Australia
On 30 July 2021, the Federal Court of Australia held that an artificial intelligence (AI) system could be validly named on a…
Article \ 18 Jun 2021
Australian innovation patent system approaches the finish line
The Australian innovation patent system is being phased out, with key changes taking place on 25 August 2021 (AEST). Steps must be…
Article \ 29 Apr 2021
Managing intangible assets for exponential growth
Intangible assets do not occupy physical space. However, they have the potential to provide high value and exponential growth when identified and…
\ 1 Jan 2021
AJ Park’s latest promotions
We are delighted to announce our latest promotions, which came into effect from 1 January 2021.
Congratulations to Dr Hannah French and Pritesh…
Article \ 3 Dec 2020
Australian High Court rejects the implied licence doctrine: establishes exhaustion…
The High Court of Australia has recently passed down a landmark 4-3 majority decision in Calidad Pty Ltd v Seiko Epson Corporation…
Article \ 30 Nov 2020
Medicinal cannabis in New Zealand – a potted summary of…
The Misuse of Drugs (Medicinal Cannabis) Regulations 2019 came into effect from 1 April 2020. These regulations establish a scheme for licencing…
Article \ 26 Nov 2020
Pesky pandemics and patents: how the conventional patent approach appears…
Over 70 vaccines and 150 drugs are currently being developed by various entities in an effort to combat the COVID-19 pandemic. Any…